We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA ANSWERS FDA WORKSHOP QUESTIONS ON BIOGENERICS
GPhA ANSWERS FDA WORKSHOP QUESTIONS ON BIOGENERICS
January 11, 2005
In a December 2004 report, the Generic Pharmaceutical Association (GPhA) offered answers to questions that the FDA posed in a September 2004 workshop on the scientific challenges of creating follow-on biologics, or biogenerics.